Carmila: Filing of the 2022 Universal Registration Document

Regulatory News:

Carmila (Paris:CARM) filed its 2022 Universal Registration Document with the French Financial Markets Authority (AMF) on 6 April 2023 under number D.23-0247.

This document is available on the Company’s website www.carmila.com and will be made available at its registered Head Office.

INVESTOR AGENDA 20 April 2023 (after market close): First-quarter 2023 financial information 11 May 2023: Annual General Meeting 25 July 2023 (after market close): First-half 2023 results 26 July 2023: First-half 2023 results presentation 19 October 2023 (after market close): Third-quarter 2023 financial information

ABOUT CARMILA

As the third-largest listed owner of commercial property in Europe, Carmila was founded by Carrefour and large institutional investors in order to transform and enhance the value of shopping centres adjoining Carrefour hypermarkets in France, Spain and Italy. At 31 December 2022, its portfolio was valued at €6.2 billion, comprising 208 shopping centres, all leaders in their catchment areas.

Carmila is listed on Euronext-Paris Compartment A under the symbol CARM. It benefits from the tax regime for French real estate investment trusts (“SIIC”).

Carmila has been a member of the SBF 120 since 20 June 2022.

Important notice

Some of the statements contained in this document are not historical facts but rather statements of future expectations, estimates and other forward-looking statements based on management’s beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results, performance or events to differ materially from those expressed or implied in such statements. Please refer to the most recent Universal Registration Document filed in French by Carmila with the Autorité des marchés financiers for additional information in relation to such factors, risks and uncertainties. Carmila has no intention and is under no obligation to update or review the forward-looking statements referred to above. Consequently, Carmila accepts no liability for any consequences arising from the use of any of the above statements.

This press release is available in the “Financial Press Releases” section of Carmila’s Finance webpage:https://www.carmila.com/en/finance/financial-press-releases

View source version on businesswire.com: https://www.businesswire.com/news/home/20230406005669/en/

INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of Investor Relations jonathan_kirk@carmila.com +33 6 31 71 83 98

PRESS CONTACT Elodie Arcayna – Corporate Communications Director elodie_arcayna@carmila.com +33 7 86 54 40 10

Carisma Therapeutics (NASDAQ:CARM)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024